Pharma

Pharma

Eli Lilly's Zepbound preferred by physicians: Spherix survey

A Spherix survey of physicians shows that injected weight loss drugs remain favored over newer oral treatments, with Lilly’s Zepbound leading the pack

Kevin Dunleavy Aug 7, 2026 11:36am

Regulatory tracker: TransThera scores key cancer nod in China

Aug 7, 2026 10:45am

lifesciencetoplinepodcastheroimagenoblepng

Inside Noble’s connected approach to patient support

Brought to you by NOBLE, Inc

showdown clash versus vs crash lightning fight dispute

The Oral GLP-1 Tracker: Lilly's Foundayo builds scripts

Aug 7, 2026 10:45am

Why the Real Risk in Hub Transition is Inertia

What Hub Transitions Really Cost Manufacturers

Brought to you by Gifthealth

Novo Nordisk makes Omnicom agency of record for US media buying

Aug 7, 2026 9:44am